Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug approved in Canada for addressing Attention-Deficit/Hyperactivity Disorder in individuals and adults . The medication functions as a prodrug, meaning https://canigetvyvanseonlineinca422349.widblog.com/98386111/vyvanse-in-canada-a-detailed-explanation